Vertex Pharmaceuticals Incorporated (VRTX) The 44th Annual William Blair Growth Stock Conference

Date:


Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) The 44th Annual William Blair Growth Stock Conference June 4, 2024 5:00 PM ET

Company Participants

Reshma Kewalramani – Chief Executive Officer

Conference Call Participants

Myles Minter – William Blair
Sami Corwin – William Blair

Myles Minter

All right, thank you very much. Welcome back to the William Blair Growth Stock Conference, the 44th Edition, as I understand it. My name is Myles Minter. I’m a Senior Biotech analyst here at the firm. I’m joined next to me by Sami Corwin, a challenging therapy expert, also a Senior Biotech analyst, and we are together to co-cover Vertex Pharmaceuticals.

It’s my pleasure to have Reshma Kewalramani here, the Chief Executive Officer of Vertex. She’s nicely taking time out to come from Boston. I live in Boston as well, and I see the building every time over in Seaport there, so it’s nice to know we’ve got a nice neighbor. Full disclosure is available at williamblair.com. Very, very briefly, I think Vertex here is the best quality and most durable growth story you can buy in biotech right now.

Obviously, have changed the way that we think about people living with cystic fibrosis with their lead candidate, TRIKAFTA, which is generating close to $10 billion as a franchise per year. But, I think the other aspect of it that I really like is that at the heart of this company is still innovation, and I think as Reshma is going to tell you they play an integral part of the commercialization of the first-ever approved crisper-based therapy for sickle cell.

We’ll hear a little bit more about that today and also hopefully a non-opioid pain alternative, which has really been a long time coming, particularly here in the U.S. So it’s enough of me talking, I’ll pass it over to Reshma.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related